SECURITIES AND EXCHANGE COMMISSION

                            WASHINGTON, D.C.  20549



                                   FORM 8-K

                                CURRENT REPORT
                      PURSUANT TO SECTION 13 OR 15(D) OF
                      THE SECURITIES EXCHANGE ACT OF 1934


               Date of Report (Date of earliest event reported)
                              SEPTEMBER 24, 1998


                      MEDIWARE INFORMATION SYSTEMS, INC.
            (Exact name of registrant as specified in its charter)


<TABLE>
<CAPTION>

<S>                             <C>                       <C>
                                        <C>                             <C>
        NEW YORK                           1-10768                        11-2209324
(State or other jurisdiction       (Commission File Number)            (I.R.S. Employer 
 of incorporation)                                                     Identification No.)
</TABLE>


           1121 OLD WALT WHITMAN ROAD, MELVILLE, NEW YORK 11747-3005
                   (Address of principal executive offices)


                                (516) 423-7800
              Registrant's telephone number, including area code


                          NO CHANGE SINCE LAST REPORT
          Former Name or Former Address, if Changed Since Last Report

<PAGE>
ITEM  2.          ACQUISITION  OR  DISPOSITION  OF  ASSETS

    On  September  24,  1998,  the  merger (the "Merger") of Informedics, Inc.
("Informedics")  into  Mediware  Acquisition  Corp.  ("MAC"),  a  wholly owned
subsidiary  of Mediware Information Systems, Inc. ("Mediware"), was effective.
The assets of Informedics include the business, products, furniture, fixtures,
equipment,  inventories,  goodwill  and  certain  intellectual  property.
Informedics  develops,  markets  and  supports  a  line  of  stand-alone
computer-based  management  information  systems for use in the blood bank and
clinical  departments  of hospitals.  Mediware intends to continue such use of
the  assets  acquired  in  the  Merger.

    On the effective date of the  Merger, Informedics shareholders of record
received  0.1587301  of  a  share of Mediware common stock, par value $.10 per
share,  for  each share of Informedics common stock, par value $.01 per share,
held by them.  The merger ratio was negotiated by the parties based upon their
determination  of  the  value of Informedics' technology and its other assets,
and  strategic  factors.

    There is no material relationship between Informedics, on the one hand, an
Mediware or any of its affiliates, any director or officer of Mediware, or any
associate  of  any  such  director  or officer of Mediware, on the other hand.
On  September  24,  1998,  Mediware  released  a press release relating to the
Merger,  a  copy  of  which  is  filed  herewith  as  Exhibit  99.

ITEM 7.     FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
     (a)          Financial  Statements  of  Businesses  Acquired.

               Financial statements of Informedics are not filed herewith but,
to  the  extent  required, will be filed within 60 days of this Report on Form
8-K.
     (b)          Pro  Forma  Financial  Information.

               Pro  forma financial information relative to Informedics is not
filed  herewith  but,  to the extent required, will be filed within 60 days of
this  Report  on  Form  8-K.

     (c)          Exhibits.

          2       Agreement and Plan of Merger among Mediware, Informedics and
MAC  dated  as of December 18, 1997, Amendment No. 1 to Merger Agreement dated
as  of  April  30,  1998  and  Amendment No. 2 to Merger Agreement dated as of
August  10,  1998  (incorporated  by  reference  to  Annex A to the Prospectus
contained  in  the  Registration  Statement  on Form S-4 (File No. 333-57693).

          99      Press  Release of Mediware, released September 24, 1998.

                                   SIGNATURE
                                   ---------
     Pursuant  to the requirements of the Securities Exchange Act of 1934, the
Registrant  has  duly  caused  this  report  to be signed on its behalf by the
undersigned  thereunto  duly  authorized.



                         MEDIWARE  INFORMATION  SYSTEMS,  INC.



                              By:          /s/    Les  Dace
                                      ----------------------
                                       Les  Dace,  President


Date:    October  9,  1998

<PAGE>
                                 EXHIBIT INDEX

          2       Agreement and Plan of Merger among Mediware, Informedics and
MAC  dated  as of December 18, 1997, Amendment No. 1 to Merger Agreement dated
as  of  April  30,  1998  and  Amendment No. 2 to Merger Agreement dated as of
August  10,  1998  (incorporated  by  reference  to  Annex A to the Prospectus
contained  in  the  Registration  Statement  on Form S-4 (File No. 333-57693).

          99      Press  Release of Mediware, released September 24, 1998.

<PAGE>
                                                  EXHIBIT  99

                                 PRESS RELEASE

      MEDIWARE ACQUIRES INFORMEDICS, INC. IN MERGER TRANSACTION AGREEMENT


MELVILLE,  N.Y.,  and  LAKE  OSWEGO,  Ore., Sept. 24/PRN Newswire/ -- Mediware
Information  Systems, Inc. (Nasdaq: MEDW; PCX: MIS) and Informedics, Inc. (OTC
Bulletin  Board:  IMED  today  announced  the  completion  of  the  merger  of
Informedics  into  a  wholly-owned  subsidiary  of  Mediware.

Under  the  terms  of  the  merger, the former shareholders of Informedics are
entitled  to  receive one share of Mediware for each 6.3 shares of Informedics
which  they  held  prior  to  the  merger.

Mediware  provides  computer based information systems for healthcare clinical
hospital  departments with its Hemocare Blood Bank System, Digimedics Pharmacy
Management  System,  and Surgiware Operating Room Management System.  Mediware
systems help healthcare organizations increase revenues and reduce costs while
improving  patient  care.

Informedics,  Inc.  develops,  markets  and  services  information  management
systems  for integrated healthcare delivery networks and medical laboratories.

This press release may contain "forward-looking statements" within the meaning
of  the  private  Securities  Litigation  Reform Act of 1995.  Such statements
involve  known  and  unknown risks, uncertainties and other factors that could
cause  the actual results of the company to differ materially from the results
expressed  or  implied  by  such  statements,  including  general economic and
business conditions, conditions affecting the industries served by the company
and  its  subsidiaries,  conditions  affecting  the  company's  customers  and
suppliers,  competitor  responses  to  the company's product and services, the
overall  market  acceptance  of  such products and services, and other factors
disclosed in the company's subsequent Quarterly Reports on Form 10-QSB through
September  30,  1997.    Accordingly,  although  the company believes that the
expectations  reflected  in  such  forward-looking  statements are reasonable,
there  can  be  no  assurance that such expectations will prove to be correct.

CONTACT: Les N. Dace, Chief Executive Officer of Mediware Information Systems,
Inc.,  408-438-4735;  or Thomas Redington of Redington, Inc., 203-222-7399, or
212-926-1733,  for  Mediware  Information  Systems,  Inc.
[{"type": "8-K", "sequence": "1", "secsgml_size_bytes": 7469}]
{"company-data": {"conformed-name": "MEDIWARE INFORMATION SYSTEMS INC", "cik": "0000874733", "assigned-sic": "7373", "irs-number": "112209324", "state-of-incorporation": "NY", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "033-40411", "film-number": "98723356"}, "business-address": {"street1": "1121 OLD WALT WHITMAN RD", "city": "MELVILLE", "state": "NY", "zip": "11747-3005", "phone": "5164237800"}, "mail-address": {"street1": "1121 OLD WALT WHITMAN RD", "city": "MELVILLE", "state": "NY", "zip": "11747-3005"}}
SECURITIES AND EXCHANGE COMMISSION

                            WASHINGTON, D.C.  20549

                                   FORM 8-K

                                CURRENT REPORT
                      PURSUANT TO SECTION 13 OR 15(D) OF
                      THE SECURITIES EXCHANGE ACT OF 1934

               Date of Report (Date of earliest event reported)
                              SEPTEMBER 24, 1998

                      MEDIWARE INFORMATION SYSTEMS, INC.
            (Exact name of registrant as specified in its charter)
NEW YORK                           1-10768                        11-2209324
(State or other jurisdiction       (Commission File Number)            (I.R.S. Employer 
 of incorporation)                                                     Identification No.)
1121 OLD WALT WHITMAN ROAD, MELVILLE, NEW YORK 11747-3005
                   (Address of principal executive offices)

                                (516) 423-7800
              Registrant's telephone number, including area code

                          NO CHANGE SINCE LAST REPORT
          Former Name or Former Address, if Changed Since Last Report
ITEM  2.          ACQUISITION  OR  DISPOSITION  OF  ASSETS

    On  September  24,  1998,  the  merger (the "Merger") of Informedics, Inc.
("Informedics")  into  Mediware  Acquisition  Corp.  ("MAC"),  a  wholly owned
subsidiary  of Mediware Information Systems, Inc. ("Mediware"), was effective.
The assets of Informedics include the business, products, furniture, fixtures,
equipment,  inventories,  goodwill  and  certain  intellectual  property.
Informedics  develops,  markets  and  supports  a  line  of  stand-alone
computer-based  management  information  systems for use in the blood bank and
clinical  departments  of hospitals.  Mediware intends to continue such use of
the  assets  acquired  in  the  Merger.

    On the effective date of the  Merger, Informedics shareholders of record
received  0.1587301  of  a  share of Mediware common stock, par value $.10 per
share,  for  each share of Informedics common stock, par value $.01 per share,
held by them.  The merger ratio was negotiated by the parties based upon their
determination  of  the  value of Informedics' technology and its other assets,
and  strategic  factors.

    There is no material relationship between Informedics, on the one hand, an
Mediware or any of its affiliates, any director or officer of Mediware, or any
associate  of  any  such  director  or officer of Mediware, on the other hand.
On  September  24,  1998,  Mediware  released  a press release relating to the
Merger,  a  copy  of  which  is  filed  herewith  as  Exhibit  99.

ITEM 7.     FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
     (a)          Financial  Statements  of  Businesses  Acquired.

               Financial statements of Informedics are not filed herewith but,
to  the  extent  required, will be filed within 60 days of this Report on Form
8-K.
     (b)          Pro  Forma  Financial  Information.

               Pro  forma financial information relative to Informedics is not
filed  herewith  but,  to the extent required, will be filed within 60 days of
this  Report  on  Form  8-K.

     (c)          Exhibits.

          2       Agreement and Plan of Merger among Mediware, Informedics and
MAC  dated  as of December 18, 1997, Amendment No. 1 to Merger Agreement dated
as  of  April  30,  1998  and  Amendment No. 2 to Merger Agreement dated as of
August  10,  1998  (incorporated  by  reference  to  Annex A to the Prospectus
contained  in  the  Registration  Statement  on Form S-4 (File No. 333-57693).

          99      Press  Release of Mediware, released September 24, 1998.

                                   SIGNATURE
                                   ---------
     Pursuant  to the requirements of the Securities Exchange Act of 1934, the
Registrant  has  duly  caused  this  report  to be signed on its behalf by the
undersigned  thereunto  duly  authorized.

                         MEDIWARE  INFORMATION  SYSTEMS,  INC.

                              By:          /s/    Les  Dace
                                      ----------------------
                                       Les  Dace,  President

Date:    October  9,  1998
EXHIBIT INDEX

          2       Agreement and Plan of Merger among Mediware, Informedics and
MAC  dated  as of December 18, 1997, Amendment No. 1 to Merger Agreement dated
as  of  April  30,  1998  and  Amendment No. 2 to Merger Agreement dated as of
August  10,  1998  (incorporated  by  reference  to  Annex A to the Prospectus
contained  in  the  Registration  Statement  on Form S-4 (File No. 333-57693).

          99      Press  Release of Mediware, released September 24, 1998.
EXHIBIT  99

                                 PRESS RELEASE

      MEDIWARE ACQUIRES INFORMEDICS, INC. IN MERGER TRANSACTION AGREEMENT

MELVILLE,  N.Y.,  and  LAKE  OSWEGO,  Ore., Sept. 24/PRN Newswire/ -- Mediware
Information  Systems, Inc. (Nasdaq: MEDW; PCX: MIS) and Informedics, Inc. (OTC
Bulletin  Board:  IMED  today  announced  the  completion  of  the  merger  of
Informedics  into  a  wholly-owned  subsidiary  of  Mediware.

Under  the  terms  of  the  merger, the former shareholders of Informedics are
entitled  to  receive one share of Mediware for each 6.3 shares of Informedics
which  they  held  prior  to  the  merger.

Mediware  provides  computer based information systems for healthcare clinical
hospital  departments with its Hemocare Blood Bank System, Digimedics Pharmacy
Management  System,  and Surgiware Operating Room Management System.  Mediware
systems help healthcare organizations increase revenues and reduce costs while
improving  patient  care.

Informedics,  Inc.  develops,  markets  and  services  information  management
systems  for integrated healthcare delivery networks and medical laboratories.

This press release may contain "forward-looking statements" within the meaning
of  the  private  Securities  Litigation  Reform Act of 1995.  Such statements
involve  known  and  unknown risks, uncertainties and other factors that could
cause  the actual results of the company to differ materially from the results
expressed  or  implied  by  such  statements,  including  general economic and
business conditions, conditions affecting the industries served by the company
and  its  subsidiaries,  conditions  affecting  the  company's  customers  and
suppliers,  competitor  responses  to  the company's product and services, the
overall  market  acceptance  of  such products and services, and other factors
disclosed in the company's subsequent Quarterly Reports on Form 10-QSB through
September  30,  1997.    Accordingly,  although  the company believes that the
expectations  reflected  in  such  forward-looking  statements are reasonable,
there  can  be  no  assurance that such expectations will prove to be correct.

CONTACT: Les N. Dace, Chief Executive Officer of Mediware Information Systems,
Inc.,  408-438-4735;  or Thomas Redington of Redington, Inc., 203-222-7399, or
212-926-1733,  for  Mediware  Information  Systems,  Inc.